The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

There was no improvement in testing rates over time. Conclusions This study demonstrates that real-life testing uptake for viral hepatitis B and C is suboptimal in the general practices in Flanders, ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The Viral Hepatitis Program is a federally funded State of Maine program dedicated to preventing and controlling viral hepatitis. This involves collaborating with local, state, and national public ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

If no other government comes forward to close the funding gap, we will face an alarming increase in transmission,' says Finn Jarle Rode, executive director of The Hepatitis Fund - Anadolu Ajansı ...